Cargando…
HPF1 completes the PARP active site for DNA damage-induced ADP-ribosylation
The anti-cancer drug target poly(ADP-ribose) polymerase 1 (PARP1) and its close homologue, PARP2, are early responders to DNA damage in human cells(1,2). Upon binding to genomic lesions, these enzymes utilise NAD(+) to modify a plethora of proteins with mono- and poly(ADP-ribose) signals that are im...
Autores principales: | Suskiewicz, Marcin J., Zobel, Florian, Ogden, Tom E. H., Fontana, Pietro, Ariza, Antonio, Yang, Ji-Chun, Zhu, Kang, Bracken, Lily, Hawthorne, William J., Ahel, Dragana, Neuhaus, David, Ahel, Ivan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104379/ https://www.ncbi.nlm.nih.gov/pubmed/32028527 http://dx.doi.org/10.1038/s41586-020-2013-6 |
Ejemplares similares
-
Serine ADP-Ribosylation Depends on HPF1
por: Bonfiglio, Juan José, et al.
Publicado: (2017) -
HPF1/C4orf27 Is a PARP-1-Interacting Protein that Regulates PARP-1 ADP-Ribosylation Activity
por: Gibbs-Seymour, Ian, et al.
Publicado: (2016) -
Bridging of DNA breaks activates PARP2–HPF1 to modify chromatin
por: Bilokapic, Silvija, et al.
Publicado: (2020) -
Serine ADP-ribosylation in Drosophila provides insights into the evolution of reversible ADP-ribosylation signalling
por: Fontana, Pietro, et al.
Publicado: (2023) -
The function and regulation of ADP-ribosylation in the DNA damage response
por: Duma, Lena, et al.
Publicado: (2023)